These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1457928)
1. Factors influencing transperitoneal calcium balance during CAPD. Kurz P; Roth P; Werner E; Vlachojannis J; Grützmacher P ASAIO J; 1992; 38(3):M589-92. PubMed ID: 1457928 [TBL] [Abstract][Full Text] [Related]
2. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations. Simonsen O; Venturoli D; Wieslander A; Carlsson O; Rippe B Kidney Int; 2003 Jul; 64(1):208-15. PubMed ID: 12787411 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798 [TBL] [Abstract][Full Text] [Related]
4. Calcium mass transfer and kinetics in CAPD using calcium-free solutions. Malberti F; Corradi B; Imbasciati E Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942 [TBL] [Abstract][Full Text] [Related]
5. Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM). Weinreich T; Colombi A; Echterhoff HH; Mielke G; Nebel M; Ziegelmayer C; Passlick-Deetjen J Perit Dial Int; 1993; 13 Suppl 2():S467-70. PubMed ID: 8399641 [TBL] [Abstract][Full Text] [Related]
6. Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/L dialysate calcium. Chagnac A; Ori Y; Weinstein T; Herman M; Korzets A; Zevin D; Hirsh J; Gafter U Am J Kidney Dis; 1999 Jan; 33(1):82-6. PubMed ID: 9915271 [TBL] [Abstract][Full Text] [Related]
7. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid. Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353 [TBL] [Abstract][Full Text] [Related]
8. [Relative hypoparathyroidism associated with CAPD treatment using normo-calcemic (3.5mEq/1) dialysate: an approach from transperitoneal calcium balance]. Shigematsu T; Hasegawa T; Utsunomiya M; Kubo H; Kato N; Hayakawa H; Yamamoto H; Nakayama M; Ogawa A; Kawaguchi Y Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):172-8. PubMed ID: 7731105 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of nitrogen balance in patients treated with continuous ambulatory peritoneal dialysis]. Janaszak S; Grzegorzewska AE; Mariak I Pol Arch Med Wewn; 1998 Dec; 100(6):499-514. PubMed ID: 10405563 [TBL] [Abstract][Full Text] [Related]
10. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824 [TBL] [Abstract][Full Text] [Related]
11. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone. Bro S; Brandi L; Olgaard K Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216 [TBL] [Abstract][Full Text] [Related]
12. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels. Montenegro J; Saracho R; González O; Moina I; Martínez I Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094 [TBL] [Abstract][Full Text] [Related]
13. Calcium mass transfer in CAPD: the role of convective transport. Montenegro J; Saracho R; Aguirre R; Martinez I Nephrol Dial Transplant; 1993; 8(11):1234-6. PubMed ID: 8302462 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal transport characteristics with glucose polymer based dialysate. Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974 [TBL] [Abstract][Full Text] [Related]
15. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate. Banalagay EE; Bernardini J; Piraino B Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941 [TBL] [Abstract][Full Text] [Related]
16. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate. Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065 [TBL] [Abstract][Full Text] [Related]
17. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis. Twardowski ZJ; Moore HL; Prowant BF; Satalowich R Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338 [TBL] [Abstract][Full Text] [Related]